GUANGDONG INV
00270
DONGFENG GROUP
00489
BJ ENT WATER
00371
COSCO SHIP PORT
01199
EB ENVIRONMENT
00257
HK Stock MarketDetailed Quotes
01875 TOT BIOPHARM-B
- 1.750
- 0.0000.00%
Not Open Dec 13 16:08 CST
1.35BMarket Cap40.70P/E (TTM)
0.000High0.000Low1.20KVolume1.750Open1.750Pre Close2.10KTurnover0.00%Turnover RatioLossP/E (Static)772.79MShares2.79052wk High1.71P/B1.35BFloat Cap1.48052wk Low--Dividend TTM772.79MShs Float6.430Historical High--Dividend LFY0.00%Amplitude0.800Historical Low1.750Avg Price400Lot Size--Div YieldTTM--Div Yield LFY
TOT BIOPHARM-B Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 49.27%809.02M | 58.69%520.6M | 67.79%222.54M | 76.54%780.63M | 77.25%541.98M | 80.24%328.06M | 65.28%132.63M | 479.34%442.18M | 744.11%305.78M | 686.87%182.02M |
| Operating income | 58.69%520.6M | 76.54%780.63M | 80.24%328.06M | 479.34%442.18M | 686.87%182.02M | |||||
| Cost of sales | ---- | -84.08%-143.7M | ---- | -188.76%-206.64M | ---- | -232.48%-78.06M | ---- | -46.49%-71.56M | ---- | -156.79%-23.48M |
| Operating expenses | -84.08%-143.7M | -188.76%-206.64M | -232.48%-78.06M | -46.49%-71.56M | -156.79%-23.48M | |||||
| Gross profit | 50.76%376.91M | 54.87%573.99M | 57.69%250M | 1,248.97%370.62M | 1,033.33%158.54M | |||||
| Selling expenses | ---- | -40.08%-276.48M | ---- | -116.23%-441.02M | ---- | -181.60%-197.38M | ---- | -792.62%-203.95M | ---- | -525.70%-70.09M |
| Administrative expenses | ---- | -3.22%-32.11M | ---- | -9.14%-68.31M | ---- | -21.04%-31.1M | ---- | -11.10%-62.59M | ---- | 4.19%-25.7M |
| Research and development expenses | ---- | 7.82%-46.06M | ---- | 31.28%-103.89M | ---- | 28.89%-49.97M | ---- | 29.59%-151.17M | ---- | 20.82%-70.27M |
| Impairment and provision | ---- | 1,868.96%9.45M | ---- | -1,823.12%-11.48M | ---- | 152.00%480K | ---- | ---597K | ---- | ---923K |
| -Other impairment is provision | ---- | 1,868.96%9.45M | ---- | -1,823.12%-11.48M | ---- | 152.00%480K | ---- | ---597K | ---- | ---923K |
| Special items of operating profit | ---- | -88.46%1.55M | ---- | 104.92%17.65M | ---- | 798.05%13.39M | ---- | 28.39%8.62M | ---- | 156.05%1.49M |
| Operating profit | 328.17%33.26M | 15.40%-33.06M | -109.79%-14.58M | 84.95%-39.08M | 93.98%-6.95M | |||||
| Financing income | ---- | 70.74%2.18M | ---- | 31.30%2.97M | ---- | 207.95%1.28M | ---- | 133.75%2.27M | ---- | -41.88%415K |
| Financing cost | ---- | -71.65%-3.88M | ---- | 21.61%-5.18M | ---- | 33.85%-2.26M | ---- | -167.50%-6.6M | ---- | -1,147.45%-3.42M |
| Share of profit from joint venture company | ---- | ---- | ---- | 62.39%-2.5M | ---- | 106.88%397K | ---- | -38,917.65%-6.63M | ---- | ---5.77M |
| Earning before tax | 308.15%31.56M | 24.56%-37.76M | 3.57%-15.16M | 80.84%-50.05M | 86.33%-15.72M | |||||
| Tax | ---- | ---- | ---- | ---1K | ---- | ---1K | ---- | ---- | ---- | ---- |
| After-tax profit from continuing operations | 308.13%31.56M | 24.56%-37.76M | 3.57%-15.16M | 80.84%-50.05M | 86.33%-15.72M | |||||
| Earning after tax | 209.30%35.4M | 308.13%31.56M | 145.24%7.41M | 24.56%-37.76M | 22.28%-32.39M | 3.57%-15.16M | -247.46%-16.38M | 80.84%-50.05M | 76.57%-41.68M | 86.33%-15.72M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---130K | ---- | ---- |
| Profit attributable to shareholders | 209.30%35.4M | 308.13%31.56M | 145.24%7.41M | 24.36%-37.76M | 20.10%-32.39M | 3.57%-15.16M | -247.46%-16.38M | 80.89%-49.92M | 77.21%-40.54M | 86.33%-15.72M |
| Basic earnings per share | 300.00%0.04 | 37.50%-0.05 | 33.33%-0.02 | 82.61%-0.08 | 85.00%-0.03 | |||||
| Diluted earnings per share | 300.00%0.04 | 37.50%-0.05 | 33.33%-0.02 | 82.61%-0.08 | 85.00%-0.03 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending HK Stocks
HK Dividend Stocks HK Dividend Stocks
Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.
